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We report an unusual case of pandemic (H1N1) 
2009–related encephalitis in an immunocompetent woman. 
Although rare cases of adult pandemic (H1N1) 2009 
associated with encephalitis have been reported previously, 
in this patient, direct viral invasion of the central nervous 
system was shown by simultaneous detection of viral RNA 
and pleocytosis.
N
eurologic complications of pandemic (H1N1) 2009 
were ﬁ  rst reported in children in May 2009 (1). Most 
subsequent reports were also of cases in children, because 
those <17 years of age appear most vulnerable (2). To our 
knowledge, only 1 retrospective review has documented 
the frequency of neurologic dysfunction among adults 
with pandemic (H1N1) 2009 (3). In this Asian cohort of 
826 hospitalized adults, seizures developed in 6 of the 9 
persons with neurologic manifestations, and none had 
encephalopathy or encephalitis. Thus, seizures appear to be 
the most common reason for seeking care for children and 
adults, followed by encephalopathy, in particular, acute 
necrotizing encephalopathy in children (4). We performed 
a Medline search of literature in English and found 5 case 
reports of adults with pandemic (H1N1) 2009 encephalitis. 
Here, we report a woman who sought care because of focal 
neurologic deﬁ  cit.
The Patient
The patient was a previously healthy 60-year-old 
housewife of Mandarin Chinese descent with well-
controlled essential hypertension. Her regular medications 
consisted of once-daily doses of bisoprolol, irbesartan-
chlorothiazide, and lercanidipine. She lived in a bungalow 
in New Taipei City, Taiwan, with her daughter and husband, 
who both remained asymptomatic. No travel, animal or 
insect contact, or inﬂ  uenza vaccination history was elicited. 
Sore throat, epiphora, and otalgia developed 3 days 
before hospital admission to Far Eastern Memorial Hospital, 
New Taipei City. High sustained fever (up to 40°C) and 
abrupt left lower face paresthesias prompted a clinic visit 
the following day. Her family physician performed a 
rapid inﬂ  uenza diagnostic test, which had negative results. 
Nevertheless, she received empirical oseltamivir, according 
to the Taiwan Department of Health’s emergent initiatives 
for the peak pandemic (H1N1) 2009 season. After 3 doses 
of oseltamivir, she remained febrile, with progressive 
anorexia, malaise, and dizziness, and sought care at the 
emergency department of a medical center.
At the emergency department (day 4 of symptoms), 
acute urinary retention developed in the patient without 
anal sphincter involvement or saddle paresthesias. Despite 
sensing urgency of her full bladder, she was unable to void 
spontaneously, necessitating catheterization. She exhibited 
no other neurologic deﬁ  cits, seizures, altered mentation, or 
meningism. Her respiratory symptoms remained mild and 
conﬁ  ned to the upper respiratory tract. Myalgia, arthralgia, 
and gastrointestinal symptoms were not prominent.
On admission, she had a temperature of 38.5°C but 
appeared well. Her blood pressure, pulse, and respiratory 
rate were 125/64 mm Hg, 89 beats per minute, and 20 
breaths per minute, respectively. Results of her physical 
examination were unremarkable except for the relative 
bradycardia (which may have been attributable to β-blocker 
use) and an above average body mass index of 28 kg/m2. 
A neurologic examination found diminished sensation 
to light touch over the distribution of her left trigeminal 
mandibular nerve. Her other cranial and peripheral nerve 
functions and higher cortical functions were grossly intact. 
Ear, nose, and throat examination revealed the normal 
appearance of bilateral eardrums and pharynx.
Initial hemogram showed borderline leukocytosis 
(10,340 cells/μL) with relative lymphopenia (17% 
lymphocytes) and a platelet count within reference range 
(210  × 103/μL). Biochemical testing revealed renal 
function, electrolytes, serum alkaline phosphatase, and 
transaminase levels within reference ranges. Plain chest 
radiographs and results of urinalysis were unremarkable. 
Electroencephalogram showed symmetric basal activities 
without epileptiform discharges. Magnetic resonance 
imaging (MRI) of the brain on day 9 of symptoms showed 
multifocal scattered T2 high-signal lesions over bilateral 
hemispheres, occipital horn, basal ganglion, and brainstem, 
involving both gray and white matter, with diffusion 
restriction (Figure, panel A). The ventriculitis correlated 
with her acute urinary retention.
Cerebrospinal ﬂ  uid (CSF) analysis was performed on 
days 8 and 11 (Table). Transition from a neutrophilic to 
a lymphocytic predominant picture was observed. CSF 
cryptococcal antigen test; Gram, India ink, and acid-fast 
stains; and subsequent bacterial, mycobacterial, and fungal 
cultures all yielded negative results. By real-time PCR 
screening of a wide panel of possible infectious etiologic 
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identiﬁ   ed in CSF, nasopharyngeal swab specimen, and 
blood on day 11.
A regimen of oseltamivir (75 mg 2×/d), initiated at 
onset of fever, was completed after 5 days. Defervescence 
occurred slowly over 2 weeks. Urodynamic study revealed 
detrusor spasticity, which was successfully treated with 
a combination of diazepam and phenazopyridine. Repeat 
brain MRI on day 24 showed near total resolution of the 
T2-hyperintense lesions (Figure, panel B). However, after 
2 months, the patient reported residual left facial numbness.
Conclusions
According to the Centers for Disease Control in 
Taiwan, the circulating inﬂ  uenza A strain for the winter-
spring season of 2011 was pandemic (H1N1) 2009 with few 
exceptions (5). The pandemic signature of novel subtype 
H1N1 has been its predilection for infecting healthy adults 
and its high transmissibility; hence, we were unable to trace 
contact history in the case described here. The patient did 
not have known comorbid risk factors; hence, her clinical 
course was mild. Epidemiologic clues to her diagnosis 
included residence in an area with the highest incidence of 
pandemic (H1N1) 2009 in Taiwan in 2011 and her naive 
immunity (lacking vaccination or exposure to the pandemic 
1918 strain). Clinical clues supporting pandemic (H1N1) 
2009 infection include initial leukocytosis as opposed to 
leukopenia, relative lymphopenia, and initial false-negative 
rapid inﬂ  uenza diagnostic test (6).
Only a few cases of pandemic (H1N1) 2009 encephalitis 
in adults have ever been reported (online Appendix Table, 
www.cdc.gov/EID/content/17/10/11-0916-appT.htm). All 
patients had altered mental status with or without seizures. 
The onset of neurologic symptoms usually occurs within 
a few days of inﬂ  uenza-like illness. Unlike children, for 
whom the mortality rate can be as high as 30% (4), most 
adults survive, despite varying degrees of sequelae. Initial 
neurologic severity parallels the severity of pulmonary 
disease and is predictive of neurologic outcomes. This case 
highlights the possibility that subtle neurologic deﬁ  cits 
may lead to underrecognition of the milder spectrum of 
central nervous system (CNS) complications associated 
with inﬂ  uenza. The patient’s report of focal paresthesias 
and micturition difﬁ   culties (in the absence of global 
neurocognitive defects) understates the substantial, albeit 
transient, CNS inﬂ  ammation captured on serial CSF and 
MRI studies. MRI patterns of CNS inﬂ  ammation in adults 
appear nonspeciﬁ  c, with T2 lesions distributed across both 
white and gray matter, with or without symmetry, brain 
necrosis, infarct, hemorrhage, edema, or ventriculitis.
This patient may be the eldest and only female adult 
reported with pandemic (H1N1) 2009 encephalitis. As 
observed, other adults were men from 20 to 40 years of age 
(online Appendix Table). There may be a yet unidentiﬁ  ed 
genetic predisposition for inﬂ  uenza-related encephalopathy 
to develop among Asians, as noted previously in children 
(4) (and possibly among male adults). A remarkable feature 
of our case was the simultaneous CNS detection of virus 
and pleocytosis, which suggests that the pathogenesis 
of subtype H1N1 encephalitis may not be simply due to 
immune activation or cytokine storm as current favored 
hypotheses propose but also may be caused by direct viral 
invasion. One possible mechanism is that the virus crosses 
the blood–brain barrier by way of the peripheral nerves 
(12). Although we cannot conﬁ  rm the entry portal of the 
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Figure. Magnetic resonance imaging with ﬂ  uid-attenuated inversion 
recovery sequence of brain for adult patient with pandemic 
(H1N1) 2009 encephalitis, Taiwan. A) On day 9 after symptom 
onset, scattered asymmetric focal hyper signal intensities over 
bilateral putamen and right thalamus (arrow on the left image) and 
ventriculitis over bilateral occipital horns (arrow head over right 
image) are seen. B) By day 24, the lesions had resolved.
Table. Sequential cerebrospinal fluid analysis for adult patient 
with pandemic (H1N1) 2009 encephalitis, Taiwan* 
Cerebrospinal fluid  Day 8  Day 11 
Reference
range 
Protein 94 78 15–40 mg/dL
Glucose 61 61 40–70 mg/dL
Lactate 2.9 2.7 1–2 mmol/L 
Leukocytes (Lymph:PMN)  244 (1:99)  64 (98:2) 0–5 L/mm
3
Erythrocytes  12 22 0/mm
3
*Lymph:PMN, lymphocytes:polymorphonuclear cells. Pandemic (H1N1) 2009 Encephalitis, Taiwan
virus, we note that when the patient sought care, she had 
a peripheral cranial nerve deﬁ  cit. Inﬂ  uenza A virus has 
been detected in the CSF of a small minority of Japanese 
children (especially in those with severe brain pathology) 
(13) and in 1 teenager in South Korea (14). In children, 
pleocytosis has rarely been described, whereas in this adult 
series, mild pleocytosis appears not infrequently (online 
Appendix Table). Despite the 2008 recommendation of 
the Infectious Diseases Society of America regarding 
routine lumbar puncture in the management of encephalitis 
for survey of possible etiologic agents (15), CSF reverse 
transcription PCR for inﬂ  uenza is infrequently performed 
in adults (online Appendix Table). Therefore, the role of 
viral CNS invasion may be underestimated.
In conclusion, physicians (not just pediatricians) 
should be alert to the possibility of neurologic disease due 
to pandemic (H1N1) 2009, especially in persons whose 
symptoms are subtle. Further studies are warranted to 
clarify and conﬁ   rm the neurotropism, particularly for 
persons of Asian heritage, of pandemic (H1N1) 2009.
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